Cancer Biology
Your Cells Are Always Trying to Become Cancer — Here's Why Most Fail
Every day, your body generates cells with mutations that could, under the right circumstances, kill you — and almost none of them do.
The Idea
Cancer isn't a foreign invasion. It's a mutiny from within — your own cells, abandoning their cooperative role in the body and reverting to something older and more selfish. What makes this stranger than it sounds is that mutation itself is constant. Every time a cell divides, it copies roughly three billion base pairs of DNA, and errors happen. By some estimates, you accumulate tens of thousands of DNA-damaging events in your cells every single day. Most are repaired. Some slip through. A very small number of those slips land in the wrong gene at the wrong time — and still, cancer remains the exception rather than the rule. The reason lies in a layered architecture of suppression. Tumour suppressor genes act as brakes; oncogenes are the accelerator. Cancer typically requires both: the accelerator stuck down and the brakes cut. Beyond that, the immune system is continuously scanning for cells displaying abnormal surface proteins and deleting them. Cells also carry built-in self-destruct programmes — apoptosis — triggered when internal damage reaches a threshold. What cancer researchers have come to appreciate is that a cell doesn't just 'go wrong' once. It has to outwit multiple independent checkpoints, accumulate what oncologist Bert Vogelstein's work showed to be a characteristic sequence of mutations, and do so in a tissue environment that is, by default, hostile to its ambitions. Cancer is less a disease of mutation and more a disease of failed suppression — which reframes the question from 'why do people get cancer?' to 'why don't we all get it constantly?'
In the World
In the 1980s, a pathologist named Bert Vogelstein at Johns Hopkins began doing something unusual: instead of studying cancer as a finished catastrophe, he tracked it backwards through its stages in colon tissue. What he mapped over years of painstaking work was a sequence — not a single mutation, but a cascade. A cell first loses function in a gene called APC, allowing it to proliferate slightly. Then a mutation in KRAS lets it grow faster. Then the loss of a tumour suppressor called p53 removes the final major checkpoint. Each step alone is survivable and correctable. All of them together, in sequence, produce a malignant tumour. This mutational portrait — sometimes called the 'Vogelgram' — transformed how oncologists think. But it also revealed something quietly alarming: researchers examining healthy colon tissue from people who had never had cancer found early APC mutations everywhere. The first step toward colon cancer appears to be extraordinarily common. The progression past it is not. More recently, scientists have found that by middle age, the oesophagus of an apparently healthy person is a patchwork quilt of clones, each carrying mutations that look pre-cancerous on paper. The body is, in a sense, perpetually negotiating with itself — a vast cellular ecosystem where the rules of cooperation are constantly tested, and constantly, quietly, upheld.
Why It Matters
Knowing that cancer is a failure of suppression rather than simply an eruption of mutation changes how you might think about prevention and early detection. It shifts the frame from 'avoid the spark' to 'protect the firebreaks' — the immune surveillance, the repair mechanisms, the tissue environments that keep mutant cells in check. Chronic inflammation, for instance, doesn't just damage DNA; it disrupts the microenvironment that suppresses rogue cells, which is one reason it correlates with so many cancers. It also makes the body's success feel remarkable rather than fragile. You are not one unlucky mutation away from disaster. You are the outcome of an extraordinarily robust system that has been filtering out these errors, in your lineage, for hundreds of millions of years. That doesn't make cancer less serious when suppression fails — but it does suggest that the dominant story of cancer as random bad luck misses something important about how much your biology is, moment to moment, working in your favour. The more precisely we understand the sequence and conditions of that failure, the better our chances of intercepting it — earlier, more specifically, and with fewer side effects than the blunt instruments we've relied on so far.
A Question to Ponder
If the earliest steps toward cancer are so common that healthy tissue carries them routinely, what does that suggest about where medicine should be directing its attention — the mutations themselves, or the conditions that allow them to progress?
Get a new one of these every morning.
Start learning with Thinkable